↓ Skip to main content

Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

policy
1 policy source
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd004157.pub2
Pubmed ID
Authors

Reto Baldinger, Hans Dieter Katzberg, Markus Weber

Abstract

Cramps are painful, involuntary muscle contractions. They commonly affect people with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) at all stages of the disease. To date, the treatment of muscle cramps in ALS has been largely empirical without any evidence from randomised controlled trials.

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 93 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 19%
Researcher 17 18%
Unspecified 14 15%
Student > Bachelor 10 11%
Student > Ph. D. Student 9 10%
Other 26 28%
Readers by discipline Count As %
Medicine and Dentistry 38 40%
Unspecified 18 19%
Nursing and Health Professions 11 12%
Psychology 6 6%
Agricultural and Biological Sciences 6 6%
Other 15 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2017.
All research outputs
#2,148,240
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#4,470
of 8,923 outputs
Outputs of similar age
#20,085
of 118,709 outputs
Outputs of similar age from Cochrane database of systematic reviews
#41
of 96 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 118,709 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.